medicine in central London. Methods-The anogenital areas of the patients were thoroughly examined using a colposcope before and after application of acetic acid. Different types of specimens were taken from a variety of anatomical sites. Superficial skin sampling was performed by the application of slides covered with "Superglue" (SG) to clinically normal and abnormal areas of anogenital skin. The presence of human cells in the SG samples was confirmed by detection of the pl-globin gene using the polymerase chain reaction (PCR). HPV DNA was extracted from the specimens and amplified by using consensus primers with the PCR. HPV types 6,11,16,18,31 and 33 were identified by Southern blotting followed by hybridisation. Results-In women, HPV DNA was detected in 83% of wart biopsies, 290%o of cervical biopsies, 36% of cervical scrapes, 25% of urethral loop specimens, 37% of vaginal washes and 33% of rectal swab specimens. In men, HPV DNA was detected in 67% of wart biopsies, 37% of urethral loop specimens and 12% of rectal swab specimens. Of the SG samples containing the ,B-globin gene, 49% from women and 50%Q from men contained HPV DNA. HPV DNA was not detected in buccal scrapes Following extraction of DNA from the specimens, the polymerase chain reaction (PCR) was used, as this is currently the most sensitive technique for the detection of HPV. 8 Southern blotting was then performed, as it allows the highly specific confirmation of DNA sequences produced by the PCR and enables the type of HPV to be determined.
Patients and methods

COLLECTION OF SPECIMENS
Patients were invited to take part in the study if either they or their sexual partner had clinically apparent anogenital warts. A standard history was taken and all patients were screened for the commonly occurring sexually transmitted diseases, and treated when appropriate. The genital and perigenital areas were then examined with the naked eye and any abnormalities documented diagrammatically. (ddH2O), 32 4uI of pronase E (10mg/ml), 28 ,ul of 2.5% sodium dodecyl sulphate (SDS) and 4 ,ul of t-RNA (0.8mg/ml). Sterile glass beads were added to the biopsy specimens to facilitate the disruption of cells during vortexing.
SG slides were abraded with a sterile disposable scalpel blade and the resulting material immersed in 320 ,1 of lysis buffer. SDS in the lysis buffer dissolved the cyanoacrylate in the specimen, releasing the sample material into the buffer.
Wart, biopsy and SG specimens were incubated in the buffer at 37°C overnight to help cells and disrupt proteins. DNA was isolated from the specimens using phenol extraction, followed by a chloroform-isoamyl alcohol (24:1) extraction and ethanol precipitation for 1 hr at -70C. The DNA pellet was collected after centrifugation for 10 min at 10,000 g, washed briefly with 70% ethanol and dried under vacuum for 30 min. The resulting pellet was then resuspended in 40 p1 ddH2O and stored at -700C until further analysis.
Urethral loops, cervical and buccal scrapes and Cytobrush specimens were agitated in 10 ml of PBS, of which 1-5 ml was subsequently used for analysis. Vaginal washes were tested directly. These samples were subsequently denatured by heating to 95°C for 10 min and then centrifuged at 10,000 g for 2 min to remove cellular debris and other extraneous material. The SG/P-F 7 SG/P-M The distribution of HPV types in the variand 5) from which samples could have been ous categories of specimens from women and taken on each occasion, 0-8 (mean 2.8) con-men is shown in table 6. HPV types 6 and 11 tained HPV DNA. Of the eight possible sites were found most frequently in the majority of in men (table 4) from which samples could specimen categories. However, the other have been taken on each occasion, [1] [2] [3] [4] [5] (mean types sought were found predominantly in the 1-25) contained HPV DNA.
non-biopsy and SG specimen categories. Of the 8 patients from whom samples were Samples taken from different sites of the taken on more than one occasion (tables same patient frequently contained the same 3-5), five had HPV DNA detected in fewer HPV type. This is illustrated by samples from sites and two in more sites than when first patients F4 and M4, the majority of which seen. In one patient, the number of sites in contained HPV type 6. However, in patients (17) 8 (24) 3 (27) 2 (29) (100) 3 (100) 11 (100) 33 (100) 11 (100) 7 (100) 13 (100) in whom multiple HPV types were detected, not all the types were found in each specimen. The frequent occurrence of multiple HPV infections has been disputed,30 but our data concerning the co-existence of multiple HPV types are consistent with those of others.3' For a given patient, specific HPV types were frequently found in common in biopsy, nonbiopsy and SG specimens, as were multiple HPV types. The failure to show crosshybridisation during the repeated experiments in which there were positive and negative controls indicates that the observations regarding multiple HPV types are not spurious.
HPV in pairs ofpartners
The persistence of HPV at various sample sites after treatment supports the findings of others32 that treatment of clinical and histological abnormalities may not necessarily eradicate infection. It is likely that persistent infection explains, at least in part, the high recurrence rate of warts regardless of the method of treatment.3 However, the occurrence of common HPV types in sexual partners noted in the current study and previously,'5 suggests that there may be an opportunity for reinfection also to play a role in the persistence of disease.
Multifocal infection of the anogenital area 
